000 | 01393 a2200409 4500 | ||
---|---|---|---|
005 | 20250513102826.0 | ||
264 | 0 | _c19970109 | |
008 | 199701s 0 0 eng d | ||
022 | _a0918-6158 | ||
024 | 7 |
_a10.1248/bpb.19.1103 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aHashimoto, Y | |
245 | 0 | 0 |
_aEffect of CYP2C polymorphisms on the pharmacokinetics of phenytoin in Japanese patients with epilepsy. _h[electronic resource] |
260 |
_bBiological & pharmaceutical bulletin _cAug 1996 |
||
300 |
_a1103-5 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 |
_aAnticonvulsants _xpharmacokinetics |
650 | 0 | 4 | _aAryl Hydrocarbon Hydroxylases |
650 | 0 | 4 | _aCytochrome P-450 CYP2C9 |
650 | 0 | 4 |
_aCytochrome P-450 Enzyme System _xgenetics |
650 | 0 | 4 |
_aEpilepsy _xmetabolism |
650 | 0 | 4 | _aGenotype |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aIsoenzymes _xgenetics |
650 | 0 | 4 |
_aPhenytoin _xpharmacokinetics |
650 | 0 | 4 | _aPolymorphism, Genetic |
650 | 0 | 4 | _aSteroid 16-alpha-Hydroxylase |
650 | 0 | 4 |
_aSteroid Hydroxylases _xgenetics |
700 | 1 | _aOtsuki, Y | |
700 | 1 | _aOdani, A | |
700 | 1 | _aTakano, M | |
700 | 1 | _aHattori, H | |
700 | 1 | _aFurusho, K | |
700 | 1 | _aIui, K | |
773 | 0 |
_tBiological & pharmaceutical bulletin _gvol. 19 _gno. 8 _gp. 1103-5 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1248/bpb.19.1103 _zAvailable from publisher's website |
999 |
_c8867520 _d8867520 |